The Living Guidelines: Initial Clinical Assessment of Patients Presenting with Heart Failure. Polling Results for CLASS III Guidelines

Any recommendations found on these pages are for education use only. WikiDoc is not a substitute for a licensed healthcare provider. Please see the disclaimers page for important information regarding limitations of the information found here. In suggesting edits to the guidelines, WikiDoc suggests that the following classification scheme be used. Read more about the classification scheme used by the ACC / AHA Guidelines Committee here.

Class III Guidelines
1. Endomyocardial biopsy should not be performed in the routine evaluation of patients with HF. (Level of Evidence: C)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class III Recommendation 1 for initial clinical assessment of patients presenting with heart failure should be: CLASS I CLASS IIa CLASS IIb CLASS III 2. Routine use of signal-averaged electrocardiography is not recommended for the evaluation of patients presenting with HF. (Level of Evidence: C)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class III Recommendation 2 for initial clinical assessment of patients presenting with heart failure should be: CLASS I CLASS IIa CLASS IIb CLASS III 3. Routine measurement of circulating levels of neurohormones (e.g., norepinephrine or endothelin) is not recommended for patients presenting with HF. (Level of Evidence: C)

 ACC / AHA Guidelines for Diagnosis and Management of Chronic Heart Failure: Class III Recommendation 3 for initial clinical assessment of patients presenting with heart failure should be: CLASS I CLASS IIa CLASS IIb CLASS III